Esophagus

Papers
(The H4-Index of Esophagus is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Role of modified Glasgow Prognostic Score in patients with achalasia who underwent laparoscopic Heller-myotomy with Dor-fundoplication376
Clinical predictors of special type of esophageal cancer167
A nationwide survey on the safety of cricothyrotomy: a multicenter retrospective study in Japan140
Effectiveness of postoperative rehabilitation after discharge in survivors of esophageal or gastroesophageal junction cancers: a systematic review88
The safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma80
Current status of prehabilitation before esophagectomy for patients with esophageal cancer among board-certified hospitals by the Japan Esophageal Society60
Modification of the lesser curvature incision line enhanced gastric conduit perfusion as determined by indocyanine green fluorescence imaging and decreased the incidence of anastomotic leakage followi38
Nationwide quality indicator survey on the current practice of esophageal cancer management in Japan: report from the guideline committee for the 6th edition of the Japanese Esophageal Cancer Practice32
Comprehensive registry of esophageal cancer in Japan, 201630
Multicenter retrospective analysis of complications and risk factors in endoscopic resection for esophageal cancer across Japan26
Novel endoscopic approaches using the endocytoscopy for the target biopsy in esophageal eosinophilia21
Comparison of anastomotic stricture rates between 23- and 25-mm powered circular staplers in cervical esophagogastric anastomosis: a propensity-matched study20
Esophagectomy for esophageal cancer in patients with a history of total pharyngolaryngectomy: a Japanese nationwide retrospective cohort study18
Conversion surgery following immunochemotherapy for initially unresectable/recurrent esophageal cancer16
Serum microRNAs for the assessment of symptomatically refractory gastroesophageal reflux disease despite acid suppression16
Outcomes of patients with esophageal squamous cell carcinoma who achieved a pathological complete response in the primary lesion by neoadjuvant treatment: a Japanese nationwide cohort study16
0.13445401191711